Sparks set to fly at Australian hearing on access to cancer drugs
This article was originally published in Scrip
A public hearing is to be held in Canberra on 20 April as part of a review of patient access to new, innovative and specialist cancer drugs in Australia that is being conducted by the Senate's Community Affairs References Committee.
You may also be interested in...
Progress is being made towards the implementation of the EU’s new patent system, but the UK’s insistence on severing all ties with the European Court could spell the end for its participation.
The recruitment process for the new executive director of the European Medicines Agency seems to be running to schedule.
Russia’s new drug traceability system won’t now be implemented until July, but companies that are ready and able are being encouraged to put the system through its paces in order to flush out any glitches.